High levels of BCL-XL driven by STAT5 have been implicated in the resistance of BCR/ABL+ chronic myelogenous leukaemia (CML) to apoptosis [199]. This evidence concerns the gene BCL2L1 and chronic myelogenous leukemia, BCR-ABL1 positive.